Greg Wilson

Greg Wilson is an experienced financial executive with a strong background in consulting and corporate finance. Currently serving as Consulting CFO for multiple organizations including Aqua Medical Inc., Aqua Heart, Inc., Aqua Therapeutics, and Que Oncology Pty Ltd since 2017, Wilson has cultivated expertise in managing financial strategies for various companies in the medical and biotechnology sectors. Additionally, Wilson holds a long-term position as CFO at Eurekster, Inc. since 2004. Previous consulting roles include positions at Sardona Therapeutics and Cleave Biosciences. Wilson's academic credentials include an MBA in Finance/Accounting from the University of Colorado Denver and a BS in Biological Science from Colorado State University.